Literature DB >> 7925270

Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences.

B O Williams1, E M Schmitt, L Remington, R T Bronson, D M Albert, R A Weinberg, T Jacks.   

Abstract

Homozygosity for a mutation in the Rb tumor suppressor gene causes mid-gestation embryonic lethality in the mouse. Using a two-step targeting protocol, we have constructed Rb homozygous mutant mouse embryonic stem cells and used them to create chimeric animals partially composed of Rb-deficient cells. Analysis of these chimeras demonstrates widespread contribution of the mutant cells to adult tissues, including the retina and mature erythrocytes. Despite the presence of large numbers of Rb-deficient cells in most tissues of these mice, they are remarkably normal but do exhibit certain histological defects including cataracts, hyperplasia of the adrenal medulla, and enlarged cells in the cerebellum and the liver. Like animals heterozygous for the Rb mutation, the chimeras develop tumors of the intermediate lobe of the pituitary, and the rate of pituitary tumorigenesis is greatly accelerated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925270      PMCID: PMC395352          DOI: 10.1002/j.1460-2075.1994.tb06745.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

2.  Transgenesis by means of blastocyst-derived embryonic stem cell lines.

Authors:  A Gossler; T Doetschman; R Korn; E Serfling; R Kemler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours.

Authors:  J M Varley; J Armour; J E Swallow; A J Jeffreys; B A Ponder; A T'Ang; Y K Fung; W J Brammar; R A Walker
Journal:  Oncogene       Date:  1989-06       Impact factor: 9.867

4.  Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine.

Authors:  J B Whitney
Journal:  Biochem Genet       Date:  1978-08       Impact factor: 1.890

5.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

6.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.

Authors:  A K Rustgi; N Dyson; R Bernards
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.

Authors:  J Yokota; T Akiyama; Y K Fung; W F Benedict; Y Namba; M Hanaoka; M Wada; T Terasaki; Y Shimosato; T Sugimura
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

9.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  90 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

Authors:  J Sage; G J Mulligan; L D Attardi; A Miller; S Chen; B Williams; E Theodorou; T Jacks
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

3.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 5.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

6.  Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion.

Authors:  Adam Pickard; Ann-Christin Cichon; Anna Barry; Declan Kieran; Daksha Patel; Peter Hamilton; Manuel Salto-Tellez; Jacqueline James; Dennis J McCance
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

7.  p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Authors:  Feng Bai; Ho Lam Chan; Matthew D Smith; Hiroaki Kiyokawa; Xin-Hai Pei
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

8.  pRb-Independent growth arrest and transcriptional regulation of E2F target genes.

Authors:  Michael T McCabe; Odinaka J Azih; Mark L Day
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

9.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

10.  Genetic evidence for functional dependency of p18Ink4c on Cdk4.

Authors:  Xin-Hai Pei; Feng Bai; Tateki Tsutsui; Hiroaki Kiyokawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.